U.S. markets open in 5 hours 42 minutes
  • S&P Futures

    3,246.00
    +8.00 (+0.25%)
     
  • Dow Futures

    26,798.00
    +83.00 (+0.31%)
     
  • Nasdaq Futures

    10,910.25
    +18.50 (+0.17%)
     
  • Russell 2000 Futures

    1,454.60
    +7.60 (+0.53%)
     
  • Crude Oil

    40.50
    +0.19 (+0.47%)
     
  • Gold

    1,878.30
    +1.40 (+0.07%)
     
  • Silver

    23.33
    +0.14 (+0.60%)
     
  • EUR/USD

    1.1675
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    0.6660
    0.0000 (0.00%)
     
  • Vix

    28.21
    -0.37 (-1.29%)
     
  • GBP/USD

    1.2783
    +0.0031 (+0.24%)
     
  • USD/JPY

    105.3750
    -0.0270 (-0.03%)
     
  • BTC-USD

    10,709.48
    -51.11 (-0.47%)
     
  • CMC Crypto 200

    218.14
    +9.20 (+4.40%)
     
  • FTSE 100

    5,842.00
    +19.22 (+0.33%)
     
  • Nikkei 225

    23,204.62
    +116.80 (+0.51%)
     

Regeneron Pharma posts quarterly profit on $228 mln gain

Aug 5 (Reuters) - Regeneron Pharmaceuticals Inc reported a quarterly profit on Wednesday that rose more than four times, helped by a $228 million gain and on higher sales of its blockbuster eczema treatment Dupixent.

Net income rose to $897.3 million, or $7.61 per share, in the second quarter ended June 30, from $193.1 million, or $1.68 per share, a year earlier.

Revenue rose to $1.95 billion from $1.58 billion. (Reporting by Dania Nadeem and Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta)